Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
Cancer
|
July 15, 1985
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)
D E Elder, D Guerry, M VanHorn, et al.
Hybridoma
|
January 1, 1985
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors
B Atkinson, C S Ernst, B F Ghrist, et al.
Plastic and Reconstructive Surgery
|
January 1, 1983
Optimal resection margin for cutaneous malignant melanoma
D E Elder, D Guerry, R M Heiberger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus
M H Greene, L R Goldin, W H Clark, et al.
Cancer Research
|
October 1, 1980
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells
M Herlyn, W H Clark, M J Mastrangelo, et al.
The American Journal of Dermatopathology
|
December 11, 1991
Early melanoma. Histologic terms
W H Clark, H L Evans, M A Everett, et al.
American Journal of Ophthalmology
|
October 15, 1984
Lack of association between intraocular melanoma and cutaneous dysplastic nevi
M R Taylor, D Guerry, E E Bondi, et al.
Journal of the American Academy of Dermatology
|
March 1, 1988
Patient and physician delay in melanoma diagnosis
B R Cassileth, L Temoshok, B E Frederick, et al.
Nature Genetics
|
September 1, 1994
Germline p16 mutations in familial melanoma
C J Hussussian, J P Struewing, A M Goldstein, et al.
The New England Journal of Medicine
|
January 10, 1985
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome
M H Greene, W H Clark, M A Tucker, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
Cancer
|
July 15, 1985
The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51-3.99 mm)
D E Elder, D Guerry, M VanHorn, et al.
Hybridoma
|
January 1, 1985
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors
B Atkinson, C S Ernst, B F Ghrist, et al.
Plastic and Reconstructive Surgery
|
January 1, 1983
Optimal resection margin for cutaneous malignant melanoma
D E Elder, D Guerry, R M Heiberger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus
M H Greene, L R Goldin, W H Clark, et al.
Cancer Research
|
October 1, 1980
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells
M Herlyn, W H Clark, M J Mastrangelo, et al.
The American Journal of Dermatopathology
|
December 11, 1991
Early melanoma. Histologic terms
W H Clark, H L Evans, M A Everett, et al.
American Journal of Ophthalmology
|
October 15, 1984
Lack of association between intraocular melanoma and cutaneous dysplastic nevi
M R Taylor, D Guerry, E E Bondi, et al.
Journal of the American Academy of Dermatology
|
March 1, 1988
Patient and physician delay in melanoma diagnosis
B R Cassileth, L Temoshok, B E Frederick, et al.
Nature Genetics
|
September 1, 1994
Germline p16 mutations in familial melanoma
C J Hussussian, J P Struewing, A M Goldstein, et al.
The New England Journal of Medicine
|
January 10, 1985
Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome
M H Greene, W H Clark, M A Tucker, et al.
Page
of 18